Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/35394
Title: | Biochemical comparison of 8 h haemodialysis and 4 h haemodiafiltration, and two dialysis membranes, in a randomized cross-over trial. | Authors: | Polkinghorne K.R. ;Kerr P.G. ;Choo S.Z. | Monash Health Department(s): | Nephrology | Institution: | (Choo, Polkinghorne, Kerr) Department of Nephrology, Monash Health, Clayton, VIC, Australia (Polkinghorne, Kerr) Department of Medicine, Monash University, Clayton, VIC, Australia (Polkinghorne) School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia | Issue Date: | 5-Mar-2020 | Copyright year: | 2019 | Publisher: | Blackwell Publishing | Place of publication: | Australia | Publication information: | Nephrology. 24 (5) (pp 542-549), 2019. Date of Publication: 01 May 2019. | Journal: | Nephrology | Abstract: | Aim: Extended-hours haemodialysis has long been regarded as the optimal form of dialysis for solute clearance. With emerging benefits of haemodiafiltration, we wanted to compare these two head-to-head. Method(s): In this randomized cross-over trial, we recruited existing nocturnal haemodialysis patients, who had not been hospitalized in the prior 3 months. After a baseline 8 h haemodialysis session, subjects were randomized to either 2 weeks of 8 h haemodialysis or 4 h haemodiafiltration with cross-over to the alternative treatment after a 2-week washout period. Subjects were additionally randomized to the Fresenius FX80 or Nipro Elisio in a parallel design. Blood and dialysate samples were collected at baseline and at the end of both study periods. Result(s): Twelve patients completed the study. Mean (SD) age and body mass index were 55.1 +/- 11.5 years and 36.4 +/- 10.8, respectively. Urea and creatinine reduction ratios were higher with extended-hours haemodialysis compared to haemodiafiltration (difference 14.0%, 95% CI = 10.6, 17.3; P < 0.001 and 9.1%, 95% CI = 11.0, 7.2; P < 0.001). Fibroblast growth factor 23 (FGF23) clearance was superior with haemodiafiltration (difference 20.1%, 95% CI = 8.7, 31.6; P = 0.001). No difference was seen in reduction ratios for phosphate, retinol binding protein, alpha-1-microglobulin, beta-2-microglobulin and fetuin with both modalities. Compared to Nipro Elisio, Fresenius FX80 dialyser achieved higher beta-2-microglobulin clearance (Period 1: difference 7.8%, 95% CI = 1.3, 14.4; P = 0.02, Period 2:7.5%, 95% CI = 1.0, 14.1; P = 0.02). Conclusion(s): Small solute clearance was superior with extended-hours haemodialysis while haemodiafiltration enhanced FGF23 clearance. Beta-2-microglobulin clearance was improved with Fresenius FX80 dialyser, but this difference is unlikely to be clinically significant.Copyright © 2018 Asian Pacific Society of Nephrology | DOI: | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1111/nep.13397 | PubMed URL: | 29722110 [http://www.ncbi.nlm.nih.gov/pubmed/?term=29722110] | ISSN: | 1320-5358 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/35394 | Type: | Article | Subjects: | human adult article clinical article cohort analysis controlled study creatinine blood level crossover procedure female *hemodiafiltration *hemodialysis hospitalization intermethod comparison male pilot study priority journal prospective study randomized controlled trial treatment duration alpha 1 microglobulin/ec [Endogenous Compound] beta 2 microglobulin/ec [Endogenous Compound] creatinine/ec [Endogenous Compound] fetuin/ec [Endogenous Compound] fibroblast growth factor 23/ec [Endogenous Compound] retinol binding protein/ec [Endogenous Compound] dialysate dialyzer Fresenius FX80 Nipro Elisio creatinine blood level crossover procedure hemodiafiltration hemodialysis hospitalization intermethod comparison pilot study alpha 1 microglobulin beta 2 microglobulin creatinine fetuin fibroblast growth factor 23 retinol binding protein dialysate dialyzer Fresenius FX80 Nipro Elisio *hemodialysis hospitalization human male pilot study priority journal prospective study randomized controlled trial treatment duration intermethod comparison adult Article clinical article cohort analysis controlled study creatinine blood level crossover procedure female *hemodiafiltration |
Type of Clinical Study or Trial: | Randomised controlled trial |
Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.